After the specificity of the anti-DDR1 antibody was verified (Supplementary Fig. S1a), we measured the expression of DDR1 in the primary ocular tumor specimens from patients with UM by using immunohistochemistry (IHC) staining with anti-DDR1. This evidence concerns the gene DDR1 and eye neoplasm.